Lexeo Therapeutics, Inc. Common Stock
Symbol: LXEO (NASDAQ)
6.62
▼ (-0.38%) -0.025
Company Description:
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
Key Stats
- Today's Open: $6.661
- Today's High: $6.661
- Today's Low: $6.615
- Today's Volume: 144
- Yesterday Close: $6.64
- Yesterday High: $6.71
- Yesterday Low: $6.36
- Yesterday Volume: 315.07K
- Last Min Volume: 144
- Last Min High: $6.661
- Last Min Low: $6.615
- Last Min VWAP: $6.661
Company Profile
- Name: Lexeo Therapeutics, Inc. Common Stock
- Website: https://www.lexeotx.com
- Listed Date: 2023-11-03
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001907108
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $358.57M
- Round Lot: 100
- Outstanding Shares: 54.00M
- Asset Type: CS
RECENT FILINGS FOR LXEO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-16 | 4 | View |
| 2025-09-10 | 4/A | View |
| 2025-09-03 | 4 | View |
| 2025-08-27 | 3 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-18 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
Latest News on LXEO